Skip to main content

Todd J. Cohen, MD, FACC, FHRS

07/31/2008
Abstract Ventricular tachycardia (VT) was mapped and ablated in a 34-year-old man with a history of a traumatic ventricular septal defect. Nonfluoroscopic three-dimensional (3D) mapping was used to guide the VT ablation. Case Report The...
Abstract Ventricular tachycardia (VT) was mapped and ablated in a 34-year-old man with a history of a traumatic ventricular septal defect. Nonfluoroscopic three-dimensional (3D) mapping was used to guide the VT ablation. Case Report The...
Abstract Ventricular...
07/31/2008
EP Lab Digest
Original Contribution
11/25/2015
This study analyzed the differences in gender and age in relation to defibrillator lead failure and mortality of patients in the Pacemaker and Implantable Defibrillator Leads Survival Study (PAIDLESS).
This study analyzed the differences in gender and age in relation to defibrillator lead failure and mortality of patients in the Pacemaker and Implantable Defibrillator Leads Survival Study (PAIDLESS).
This study analyzed the...
11/25/2015
Journal of Invasive Cardiology
Review
03/31/2015
With new methods of radiation protection, radiation exposure in the EP lab may become minimal to nonexistent in the near future. This is good news for EP doctors and staff. 
With new methods of radiation protection, radiation exposure in the EP lab may become minimal to nonexistent in the near future. This is good news for EP doctors and staff. 
With new methods of radiation...
03/31/2015
EP Lab Digest
Case Report
12/08/2008
Author Affiliations: From the Electrophysiology Department, Winthrop University Hospital, Mineola, New York. The authors report no conflicts of interest regarding the content herein. Manuscript submitted May 30, 2008, provisional...
Author Affiliations: From the Electrophysiology Department, Winthrop University Hospital, Mineola, New York. The authors report no conflicts of interest regarding the content herein. Manuscript submitted May 30, 2008, provisional...
Author Affiliations: From the...
12/08/2008
Journal of Invasive Cardiology
Case Report
11/30/2014
This case highlights the potential applications of a novel, miniaturized, subcutaneous injectable loop recorder for the diagnosis and treatment of syncope of unknown etiology, potentially helping with a previously undiagnosed neurological...
This case highlights the potential applications of a novel, miniaturized, subcutaneous injectable loop recorder for the diagnosis and treatment of syncope of unknown etiology, potentially helping with a previously undiagnosed neurological...
This case highlights the...
11/30/2014
EP Lab Digest
Guest Editorial
05/03/2008
Dr. Karch and colleagues describe the results of right atrial mapping with a 64-pole basket catheter during persistent, induced sustained, and nonsustained atrial fibrillation. One implication which may be gathered from their report is that...
Dr. Karch and colleagues describe the results of right atrial mapping with a 64-pole basket catheter during persistent, induced sustained, and nonsustained atrial fibrillation. One implication which may be gathered from their report is that...
Dr. Karch and colleagues...
05/03/2008
EP Lab Digest
Electrophysiology Corner
08/01/2008
The percutaneous implantation of left ventricular leads in patients with congestive heart failure can be difficult in approximately 5% of implants. A variety of curved introducer sheaths, guidewires and steerable electrophysiology catheters...
The percutaneous implantation of left ventricular leads in patients with congestive heart failure can be difficult in approximately 5% of implants. A variety of curved introducer sheaths, guidewires and steerable electrophysiology catheters...
The percutaneous implantation of...
08/01/2008
Journal of Invasive Cardiology
Perspectives
05/03/2008
Recently, the U.S. FDA approved MADIT II indications for the implantable cardioverter-defibrillator. Specifically, they find that it is an acceptable indication for implanting these devices in patients who have experienced myocardial...
Recently, the U.S. FDA approved MADIT II indications for the implantable cardioverter-defibrillator. Specifically, they find that it is an acceptable indication for implanting these devices in patients who have experienced myocardial...
Recently, the U.S. FDA approved...
05/03/2008
EP Lab Digest
05/03/2008
Electrocautery has long been described to generate electromagnetic interference (EMI) and oversensing by implanted pacemakers and defibrillators. Electrocautery is commonly used during surgical procedures involving implantation and...
Electrocautery has long been described to generate electromagnetic interference (EMI) and oversensing by implanted pacemakers and defibrillators. Electrocautery is commonly used during surgical procedures involving implantation and...
Electrocautery has long been...
05/03/2008
EP Lab Digest
Original Contribution
05/29/2015
Implantable lead survival has been the subject of many multicenter studies over the past decade. The purpose of this study was to examine survival in the implantable defibrillator subset of implanted leads at a large-volume implanting...
Implantable lead survival has been the subject of many multicenter studies over the past decade. The purpose of this study was to examine survival in the implantable defibrillator subset of implanted leads at a large-volume implanting...
Implantable lead survival has...
05/29/2015
Journal of Invasive Cardiology